Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Researchers Report Chemical Reaction with Potential to Speed Drug Development

By UT Southwestern Medical Center | July 10, 2017

Chemists have long sought to develop new reactions for the direct conversion of simple hydrocarbon building blocks into valuable materials such as pharmaceuticals in a way that dependably creates the same chemical bonds and orientations. UT Southwestern researchers have hit upon a novel way to do that.

The ability to consistently create desirable molecules and avoid undesirable ones could greatly accelerate pharmaceutical production. Many molecules come in two mirror-image configurations, often labeled left-handed and right-handed. Usually, only one of the two is biologically desired, but the issue is more complicated than that, said Dr. Uttam Tambar, Associate Professor of Biochemistry and senior author of a studyoutlining the reaction published online in Nature.

“Unsaturated hydrocarbons contain only two types of bonds, carbon-hydrogen and carbon-carbon. It is very challenging to selectively transform the starting material hydrocarbon, called the feedstock, into a product in which you have selectively transformed one carbon-hydrogen bond into a new bond in every molecule. We are able to do that,” Dr. Tambar said.

“We are not only dealing with left- or right-handed configuration; we are also dealing with what position of the molecule is chemically modified,” he added.

The selectivity problem challenges chemists, who often encounter it when attempting to directly transform unsaturated hydrocarbons that contain one or more carbon-carbon double bonds, resulting in difficult-to-separate mixtures of compounds that require subsequent chemical steps to subdivide the mixtures into the desired molecules.

“We have developed a method for the direct conversion of a variety of double bond-containing materials into useful products. A specially designed chiral catalyst is used to oxidize hydrocarbons into multifunctional compounds that are obtained in high purity and are readily converted into an assortment of molecules that will streamline the synthesis of future pharmaceutical drugs,” said Dr. Leila Bayeh, a former graduate student and lead author of the study. Dr. Bayeh is now a postdoctoral researcher at the Massachusetts Institute of Technology.

The phrase “chiral catalyst” means that the catalyst that orchestrates the entire reaction has the proper orientation – a left- or right-handed configuration as the situation requires – in order to create the desired chemical transformation, he explained.

The orientation and proper location of all chemical bonds is crucial because the wrong molecule generated from a reaction can be ineffectual or potentially dangerous.

Hence the emphasis on consistency.


Filed Under: Drug Discovery

 

Related Articles Read More >

In door grow hemp. Cannabis at the beginning of flowering. Legal Marijuana cultivation in the home. Green background of leaves. Young cannabis plant. Medicinal indica with CBD.
Why Schedule III cannabis could be a win for Big Pharma
Red blood cells macro over red eritrosit background. Concept of blood cells count, medicine and healthcare. 3d rendering mock up
Platelet-inspired nanoparticle delivers drugs directly where they are needed
Lilly’s triple agonist delivers up to 71.2 lbs of weight loss in Phase 3 trial
China’s biopharma sector enters ‘innovation 2.0’ era
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE